Biotech Beach
Filter News
Found 77,263 articles
-
ICU Medical, Inc. Announces Time of First Quarter Earnings Call
4/18/2007
-
2007 Recipients of Amgen Award for Science Teaching Excellence Announced
4/18/2007
-
CFO of instaCare Corp. to Air in Live MN1 Interview
4/18/2007
-
ACADIA Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences
4/18/2007
-
Ferring Pharmaceuticals Reports on ENDOMETRIN(R) Presentations at Pacific Coast Reproductive Society Annual Meeting
4/18/2007
-
Amgen (Jobs) Details Higher Death Risk in Aranesp Trial
4/17/2007
-
Breastfeeding May Protect Against Breast Cancer
4/17/2007
-
Extreme-Living Bacteria Has Genome Sequenced
4/17/2007
-
Prognosis: Predicting Cancer Risk in the Long-Term
4/17/2007
-
Nanogen, Inc. Submits 510(K) for Cystic Fibrosis Genetic Assay and NanoChip(R) 400 System
4/17/2007
-
Cardium Therapeutics, Inc. Announces Automated Infusion System for Generx Phase 3 AWARE Study
4/17/2007
-
Lorus Therapeutics Inc. Announces Scientific Presentations for Lead Antisense and siRNA Drug Candidates at International Cancer Conference
4/17/2007
-
Cougar Biotechnology, Inc. Presents Positive CB7630 Clinical Data at American Association for Cancer Research Annual Meeting Late-Breaking Clinical Trials Session
4/17/2007
-
Metabasis Therapeutics, Inc. Presents Results of a Clinical Study for Its Novel Liver-Targeted Product Candidate for the Treatment of HCC at American Association for Cancer Research
4/17/2007
-
CERVARIX(R), GlaxoSmithKline Cervical Cancer Candidate Vaccine, Demonstrates 100 Percent Protection Against Precancerous Lesions Caused By Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than Five Years
4/17/2007
-
FDA Approves Fast Track Designation for Naryx Pharma, Inc.'s Product for Chronic Sinusitis
4/17/2007
-
AVEO Pharmaceuticals, Inc. Presents Preclinical Efficacy Data on AV-412, a Novel Oral Tyrosine Kinase Inhibitor of EGFR/HER2 for EGFR Mutant and Drug-Resistant Lung Cancer
4/17/2007
-
Peregrine Pharmaceuticals, Inc. Data Presented at American Association for Cancer Research Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Growth of Both Hormone-Dependent and Hormone-Independent Prostate Cancer by Up to 94 Percent in Preclini
4/17/2007
-
Anadys Pharmaceuticals, Inc. Reports Preclinical Data Showing ANA773 Promotes Anti-Tumor Activity of Natural Killer Cells
4/17/2007
-
ProNAi Therapeutics, Inc. Announces Preclinical Success for PNT2258 Therapeutic - Curative Events in Xenograft Mice for Difficult-to-Treat Non-Hodgkin's Lymphoma
4/17/2007